Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16891
Title: Changing face of robot-assisted radical prostatectomy in Melbourne over 12 years
Austin Authors: Sathianathen, Niranjan J;Lamb, Alastair;Lawrentschuk, Nathan;Goad, Jeremy R;Peters, Justin;Costello, Anthony J;Murphy, Declan G;Moon, Daniel A
Affiliation: Department of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Division of Cancer Surgery, Department of Genitourinary Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Department of Urology, Royal Melbourne Hospital, Melbourne, Victoria, Australia
Australian Prostate Cancer Research Centre, Epworth Healthcare, Melbourne, Victoria, Australia
Issue Date: Mar-2018
metadata.dc.date: 2017-09-18
Publication information: ANZ Journal of Surgery 2018; 88(3): E200-E203
Abstract: BACKGROUND: This study aims to characterize the trends in disease presentation for robot-assisted radical prostatectomy (RARP) over a 12-year period in Melbourne, Australia. METHODS: All patients undergoing an RARP between 2004 and October 2016 while under the care of six high-volume surgeons were included in this study. Data were collected prospectively regarding patient demographics and clinical details of their cancer. RESULTS: Over the 12-year time span of the study, 3075 men underwent an RARP with a median age of 63.01 years. Temporal analysis demonstrated that the median age of patients undergoing prostatectomy advanced with time with the median age in 2016 being 65.51 years compared with 61.0 years in 2004 (P < 0.001). There was also a significant trend to increased D'Amico risk groups over time with the percentage procedures for high-risk patients increasing from 12.6% to 28.10% from 2004 to 2016 (P < 0.001). Upgrade rates between biopsy and pathological Gleason grade scoring significantly trended down over the period of the study (P < 0.001). There was also a shift to increased pathological stage over the 12 years with 22.1% of men having T3 disease in 2004 compared with 49.8% in 2016. CONCLUSION: Our analysis demonstrates increasing treatment of older men with higher risk tumours, consistent with international trends. While this largely reflects a shift in case selection, further work is needed to assess whether the stage shift may relate partially to a decline in screening and increased presentation of higher risk disease.
URI: http://ahro.austin.org.au/austinjspui/handle/1/16891
DOI: 10.1111/ans.14169
ORCID: 0000-0001-8553-5618
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/28922689
Type: Journal Article
Subjects: Laparoscopic surgery
Prostate cancer
Prostatectomy
Robotic surgical procedure
Appears in Collections:Journal articles

Show full item record

Page view(s)

2
checked on Nov 25, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.